Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Bob Holland

Premium

Bob Holland has joined Oxford Gene Technology as its chief medical officer.

Holland previously served as vice president and head of AstraZeneca's Personalized Healthcare and Biomarkers division.

In his new role at OGT, Holland will lead clinical affairs across OGT's business areas. He will work with the UK company's R&D and commercial teams to develop clinical development programs that will expand its next-generation sequencing and microarray cancer profiling solutions. Holland will also work with OGT's biomarker programs for prostate and colorectal cancers, OGT said.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.